Inlyta (axitinib tablets - Pfizer) — Cigna
Thymic carcinoma
Initial criteria
- Patient is age ≥ 18 years
- Patient has tried at least one chemotherapy regimen
- Medication will be used in combination with Bavencio (avelumab intravenous infusion)
Approval duration
1 year